'Patients pay the tariff': Swiss pharma CEO warns of Trump's generic drug tariff threat

Sandoz CEO Richard Saynor warns steep U.S. tariffs on imported generic drugs could force manufacturers to raise prices or cut supply. American patients would ultimately bear the cost of President Donald Trump 's threatened tariffs on generic drugs, the CEO of Swiss pharmaceutical company Sandoz told CNBC, warning that manufacturers could be forced to raise prices or stop supplying some medicines [1].

Sources

1. cnbc.com · 'Patients pay the tariff': Swiss pharma CEO warns of Trump's generic drug tariff threat Sep 9, 2026

This is the neutral brief the press writes once, for everyone, before each reader’s paper adds its own so-what. It links out; it does not republish. 1 article clustered.

Print your own paper